MilliporeSigma announced a collaboration with IPS (Integrated Project Services) and G-CON Manufacturing. The deal will extend MilliporeSigma’s BioReliance End-to-End offering by integrating MilliporeSigma’s single-use process equipment, end-to-end process development capabilities and cGMP manufacturing experience into the iCON facility design platform.

“Biologics are helping to fight some of the toughest diseases worldwide, and demand for these therapies continues to grow,” said Andrew Bulpin, head of Process Solutions at MilliporeSigma. “This collaboration is an innovative concept built upon MilliporeSigma’s years of experience in designing, constructing and running cGMP biologics production, combined with the iCON facility, team and design platform. It will decrease time-to-market and accelerate access to biologics to improve the lives of patients around the world.”

The integrated offering will deliver a platform for fast and flexible deployment of 2,000L MAb production facilities. The hallmarks of the combined solution will include pre-fabricated cleanroom units, a structural platform based on cost-effective pre-engineered building delivery, bioprocess and single-use equipment expertise, as well as turnkey facilities capable of fast-track deployment.